Heart Failure

Estrogen may protect against heart failure (HF)-related depression by preventing the creation of inflammation-causing chemicals in the brain, according to research published in the American Journal of Physiology.
Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy.
Home-delivered sodium-restricted Dietary Approaches to Stop Hypertension (DASH/SRD) meals after heart failure (HF) hospitalizations appeared safe in some patients, has the potential to improve HF symptoms and can reduce readmissions, according to new research in Circulation: Heart Failure.
Shorter reperfusion times for patients with ST-segment elevation myocardial infarction (STEMI) are associated with fewer cases of in-hospital heart failure and fewer readmissions for heart failure over the next 30 days, according to an observational study from Singapore published in Circulation: Cardiovascular Quality and Outcomes.
Adult congenital heart disease (ACHD)-related heart failure (HF) hospitalizations have increased in recent years and are associated with disproportionately higher costs, procedural burden and health resource use, according to new research published in the Journal of the American Heart Association.
In a single-center study of smokers with heart failure, those who also had emphysema identified by CT were twice as likely to be rehospitalized for heart failure in the following two years.
While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of the American College of Cardiology notes individuals treated with trastuzumab-based chemotherapy have a higher risk for HF—but they are not monitored for it, despite recommendations.
A program designed to provide rapid follow-up visits to heart failure patients after hospital discharge improved 30-day survival, reduced readmissions and saved money, according to a retrospective study published in the American Journal of Medical Quality.
A protein known to protect brain function in the setting of Duchenne muscular dystrophy may also have a positive impact on the heart, according to preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences scientific sessions on Aug. 1 in San Antonio.
Continually updated mortality models based on adverse events and end-organ function are better at showing which transplant candidates most urgently require a new heart, according to a study published in the Journal of the American College of Cardiology.
A simple measure of waist circumference could identify chronic heart failure patients who would benefit most from mineralocorticoid receptor antagonists, according to a review published July 25 in JAMA Cardiology.
In following patients with heart failure for up to 15 years, Spanish cardiologists found left ventricular ejection fraction (LVEF) followed an inverse U-shape: LVEF improved for the first year, then plateaued for the rest of the first decade and declined in the following years—especially before death.
Italian physicians reported what they believe to be “unprecedented clinical improvement” from interleukin-1 suppression in a patient with dilated cardiomyopathy.
A group of researchers from a Veterans Affairs health system in California shared their experience with limited left ventricular echocardiography, something they believe could reduce the cost and time required for testing in select patients.
Twice as many U.S. deaths due to cardiac amyloidosis were reported in 2015 than in 1979, but a study in JAMA Cardiology suggests the disease remains vastly underdiagnosed.
Jul 18, 2018 | Heart Failure
Despite decreases in heart failure (HF) incidence and mortality rates in ambulatory patients, mortality remains higher for women, according to a new study published July 16 in the Canadian Medical Association Journal.
Heart Failure
Jul 17, 2018 | Heart Failure
Stem cells can be used to “encourage” better function in heart failure (HF) patients in the U.K., according to a recent stem cell therapy trial spearheaded by researchers from the University of Edinburgh. Harvested from bone marrow, the stem cells, which were able to generate new cardiac tissue and blood vessels, had a success rate of 80 percent.
Heart Failure
Jul 17, 2018 | Heart Failure
Despite guidelines and quality improvement efforts, many people with heart failure with reduced ejection fraction (HFrEF) aren’t prescribed the recommended medications. And among those who are, fewer than one-fourth receive optimal doses, according to a registry analysis of ambulatory patients.
Heart Failure, Practice Management
Jul 16, 2018 | Heart Failure
In the U.S., candidates for heart transplantation are prioritized by the intensity of treatment they’ve received, potentially leading some centers to overtreat patients.
Heart Failure
Jul 16, 2018 | Hypertension
The FDA on Friday, July 13, joined more than 20 other countries in recalling medications containing valsartan, an active ingredient used to treat hypertension and heart failure. Some of the medications with valsartan have been contaminated with N-nitrosodimethylamine (NDMA), a probable human carcinogen.
Hypertension, Heart Failure, Healthcare Economics & Policy
Jul 13, 2018 | Heart Failure
A new study, published July 11 in the Journal of the American Medical Association, suggests heart failure (HF) may be moderately hereditary.
Heart Failure